Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection.
Conclusions: The eradication rate of the 7-HEAC group was higher than that of the 7-NEAC group. Nevertheless, more effective first-line therapies may be necessary for H. pylori eradication in the near future.
PMID: 32969362 [PubMed - in process]
Source: Korean J Gastroenter... - Category: Gastroenterology Authors: Lee YD, Kim SE, Park SJ, Park MI, Moon W, Kim JH, Jung K, Song J Tags: Korean J Gastroenterol Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Esomeprazole | Gastroenterology | Helicobacter Pylori | Nexium | Proton Pump Inhibitors PPIs | Study